Forbes November 14, 2024
Erez Meltzer

Erez Meltzer, CEO & Board Member of Nanox, is a prominent Israel business leader with 35+ years experience leading various global companies.

The promise of personalized medicine is finally becoming a reality. Thanks to the advent of artificial intelligence (AI), we’re witnessing a transformation in patient care that goes beyond incremental improvements. AI is now reshaping how we approach diagnostics, treatment planning and ongoing patient management, offering the potential for truly individualized healthcare at scale.

While the concept of personalized medicine isn’t new, the ability to implement it effectively has been limited by the sheer complexity of human biology and the vast amount of data involved. This is where AI shines, offering the computing power and analytic capabilities to process...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Provider, Technology
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article